Literature DB >> 23592327

Photostability of crystalline versus amorphous nifedipine and nimodipine.

Driekus Grooff1, Farzaana Francis2, Melgardt M De Villiers3, Ernst Ferg2.   

Abstract

True solid-state photostability of the drugs nifedipine and nimodipine was investigated during exposure to UV-visible radiation. Photostability was studied on a small scale as thin films of approximately 1 mg drug, which contained either amorphous or re-crystallised stable phases. High-performance liquid chromatography analysis revealed a greater rate and extent of decomposition for the amorphous phases. Photoexposed amorphous nifedipine exhibited approximately 1.8-fold larger first-order decomposition rate constant (k) relative to its crystalline phase. The increase in k was more significant for photoexposed amorphous nimodipine at approximately sixfold relative to its crystalline phase. Photodecomposition in scaled-up samples of the stable crystalline phases for both drugs was monitored with X-ray diffraction in Bragg-Brentano geometry. The similarities in the calculated photodecomposition extents to results from small scale validated the specificity of the X-ray analysis technique to the photodecomposition region. The considerably faster decomposition rates in small-scale studies were attributed to a maximised surface area (A) for quantity (m0 ) of exposed drug. Kinetic interpretations of true solid-state stability should consider the sample solid dimensions in terms of the direct exposed A and m0 in the photodecomposition region, that is, outer layers in solid.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23592327     DOI: 10.1002/jps.23533

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

Review 1.  Clays as Vehicles for Drug Photostability.

Authors:  Monsuêto C da Rocha; Thais Galdino; Pollyana Trigueiro; Luzia M C Honorio; Raquel de Melo Barbosa; Santiago M Carrasco; Edson C Silva-Filho; Josy A Osajima; César Viseras
Journal:  Pharmaceutics       Date:  2022-04-05       Impact factor: 6.525

2.  Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains.

Authors:  Ellen K Wasan; Jinying Zhao; Joshua Poteet; Munawar A Mohammed; Jaweria Syeda; Kevin Soulsbury; Jacqueline Cawthray; Amanda Bunyamin; Chi Zhang; Brian M Fahlman; Ed S Krol
Journal:  Pharmaceutics       Date:  2019-11-09       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.